INAQOVI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for INAQOVI, covering 2025-03-10 to 2026-07-17. Get the full timeline:
Most recent: EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.